Evaluation of the Efficacy of Streptococcus Salivarius Evol12® in the Reduction of Recurrent Adenotonsillitis in Children

NCT07235826 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Tonsillitis

Interventions

DIETARY_SUPPLEMENT: Bactoblis® Evol (Streptococcus salivarius Evol12®)
OTHER: Placebo

Sponsor

Liaquat University of Medical & Health Sciences

Collaborators

[object Object]